Aster DM Healthcare shares jump 14%; here’s why
The healthcare company has announced a special dividend of ₹118 per share for its shareholders on account of the receipt of proceeds from the sale of the GCC business.
The healthcare company has announced a special dividend of ₹118 per share for its shareholders on account of the receipt of proceeds from the sale of the GCC business.
Olympus Capital Asia Investments is reportedly looking to sell a 9.8% stake in Aster DM Healthcare for up to ₹1,953 crore (nearly $235 million).
ZAP-X gyroscopic radiosurgery platform is designed for the treatment of brain tumours, offering non-invasive, pain-free sessions lasting 30 minutes.
The innovation segment is dominated by pharma services (CDMO, CRO, pharma IT) and health-tech with vaccines and biotech, and med-tech emerging as green shoots
The stock has maintained an uptrend for the fifth consecutive session and rose 22.5% during this period, while it gained 17% in a month.
Investments rise but companies ask for more hand-holding and incentives to make India a manufacturing base.
Entero Healthcare Solutions plans to raise ₹1,000 crore via fresh issue and ₹600 crore through OFS route
The industry expects an enhanced healthcare spend of 2.5% of GDP to boost infrastructure and R&D activities.
Women occupy only 18% of healthcare leadership positions and continue to earn 34% less than their male counterparts.
The healthcare firm plans to split India and GCC (Gulf Cooperation Council) businesses into separate entities and divest gulf business for $1 billion.